The Denmark-based drug maker Zealand Pharma said Tuesday that its experimental weight-loss drug could help patients lose ...

Zealand Pharma A/S said moderate doses of its experimental weight-loss drug helped patients pare pounds with less nausea than ...

Poorer folks' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found. Only 13 ...

While expected and seen as largely incremental, Jefferies analyst Peter Welford in a Tuesday note to investors said the detailed data for three early-stage assets support moving them into Phase IIb ...

Welcome to the healthier, happier world of 2030. Heart attacks and strokes are down 20%. A drop in food consumption has left ...

Some patients are using lower-than-recommended dosages of generic weight-loss drugs to slim down ... As powerful anti-obesity ...

Those market dynamics will again be in focus when Novo reports results for its diabetes drug Ozempic and weight-loss medicine ... said Dr. Holly Lofton of New York University Langone, a general ...

Novo Nordisk (NVO), the maker of blockbuster weight-loss and diabetes drugs Wegovy and Ozempic, has entered an agreement with Denmark-based Ascendis Pharma (ASND) to leverage the latter’s advanced ...

AstraZeneca said its experimental weight loss pill was well tolerated by patients in an early-stage clinical trial. The Anglo ...

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale ... said Dr.

Here’s what obesity ... Food and Drug Administration (FDA) to help patients with type 2 diabetes with blood sugar management. However, it’s often used off-label for weight loss, since research ...

Here's all you need to know about Ozempic that Karan Johar is said to have used for fast weight loss. What are the benefits and possible health risks? Controversial weight loss drug linked to ...